Donald Joseph's Net Worth
-$16.5 Thousand
Who is Donald Joseph?
Donald Joseph does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include RENOVIS INC, KALOBIOS PHARMACEUTICALS INC, ACHIEVE LIFE SCIENCES, INC., Acer Therapeutics Inc., and ABGENIX INC.
SEC CIK
Donald Joseph's CIK is 0001319460
Past Insider Trading and Trends
2019 was Donald Joseph's most active year for acquiring shares with 3 total transactions. Donald Joseph's most active month to acquire stocks was the month of April. 2006 was Donald Joseph's most active year for disposing of shares, totalling 2 transactions. Donald Joseph's most active month to dispose stocks was the month of March. 2020 saw Donald Joseph paying a total of $49,997.50 for 36,285 shares, this is the most they've acquired in one year. In 2006 Donald Joseph cashed out on 150,939 shares for a total of $21,127.50, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
RENOVIS INC No price found
SVP, Gen. Counsel & Secretary
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -50.00K |
—
|
—
|
0
|
Jan 3
| |||
Form 4
|
∞
| 50K |
—
|
—
| 50K |
May 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
KALOBIOS PHARMACEUTICALS INC (HGEN) Snapshot price: $0.011
Chief Legal Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ACHIEVE LIFE SCIENCES, INC. (ACHV) Snapshot price: $4.365
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 20
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Aug 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Acer Therapeutics Inc. (ACER) Snapshot price: $0.8675
See Remarks
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -14.29K |
—
|
—
|
0
|
Nov 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 15
| |||
Form 4
|
∞
| 14.29K |
$3.50 | $49,997.50 | 14.29K |
Jul 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ABGENIX INC No price found
Senior VP, Gen. Counsel & Sec.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -939.00 |
$22.50 | -$21,127.50 |
0
|
Apr 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||